UiPath Inc. (NYSE:PATH) is one of the Cheap AI Stocks to Buy According to Analysts. On April 27, UiPath and Deloitte expanded their collaboration to accelerate software development, testing, and deployment for global organizations. The joint solution integrates UiPath Test Cloud capabilities into Deloitte’s Ascend engineering and service delivery platform.
The partnership focuses heavily on agent AI, enabling autonomous quality through AI agents working alongside human raters. Powered by agent AI, the solution proactively detects system changes, generates tests, and executes them autonomously. Testers can use these AI agents to analyze thousands of test results, identify root causes, and discover failure patterns.
By incorporating UiPath Inc.’s (NYSE:PATH) Tester Autopilot and Agent Builder into Ascend, teams can use pre-built test robots and domain-specific AI agents. This AI-powered integration is designed to automate manual tasks such as test design and reduce maintenance by performing self-healing, resulting in broader test coverage, faster release cycles, and higher automation ROI.
UiPath Inc. (NYSE:PATH) is an AI-powered software infrastructure company that integrates generative and agent AI with RPA/robotic process automation through its core offering, the UiPath platform.
While we recognize PATH’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 33 stocks that should double in 3 years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.